InflaRx NV
NASDAQ:IFRX

Watchlist Manager
InflaRx NV Logo
InflaRx NV
NASDAQ:IFRX
Watchlist
Price: 2.24 USD 5.16%
Market Cap: 131.9m USD
Have any thoughts about
InflaRx NV?
Write Note

Intrinsic Value

IFRX's intrinsic value estimate is unreliable because it is based only on its multiples and doesn't use a DCF valuation.

The intrinsic value of one IFRX stock under the Base Case scenario is 1.95 USD. Compared to the current market price of 2.24 USD, InflaRx NV is Overvalued by 13%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

IFRX Intrinsic Value
1.95 USD
Overvaluation 13%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation History
InflaRx NV

Intrinsic Value History
Dive into the past to invest in the future

Uncover deeper insights with the Valuation History. Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Start now and learn if your stock is truly undervalued or overvalued!

Start Valuation
Backtest Conclusion
Very Attractive
Current Valuation
+45%
Avg Valuation
-12%
Worst Valuation
-49%
Best Valuation
+45%

Stock is trading at its lowest valuation over the past 5 years.

Backtest Example
Register to View Results
Register to View Results

To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.

Valuation History Unavailable

Historical valuation for IFRX cannot be conducted due to limitations such as insufficient data or other constraints.

Valuation In Progress...
Valuation In Progress...
How do you feel about IFRX?
Bearish
Neutral
Bullish

Fundamental Analysis

2.24 USD
+5.16%
+5.16%
Benchmark
Company Quality
No Indicators Selected
Select Indicators

Select up to 3 indicators:

Insider Trading
0-3
Months
0-6
Months
0-12
Months
0-36
Months
No Periods Selected
Select Periods

Select up to 2 periods:

InflaRx NV
DE
Biotechnology
Market Cap
131.9m USD
IPO
Nov 16, 2017
Employees
59
Germany
Market Cap
131.9m USD
Industry
Biotechnology
IPO
Nov 16, 2017
Company Overview
Loading...
Economic Moat
Loading...
Earnings Call
Loading...
Management
Loading...
Contacts
Loading...
AI Assistant
AI Assistant
Ask me anything about InflaRx NV

Provide an overview of the primary business activities
of InflaRx NV.

What unique competitive advantages
does InflaRx NV hold over its rivals?

What risks and challenges
does InflaRx NV face in the near future?

Summarize the latest earnings call
of InflaRx NV.

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for InflaRx NV.

Provide P/S
for InflaRx NV.

Provide P/E
for InflaRx NV.

Provide P/OCF
for InflaRx NV.

Provide P/FCFE
for InflaRx NV.

Provide P/B
for InflaRx NV.

Provide EV/S
for InflaRx NV.

Provide EV/GP
for InflaRx NV.

Provide EV/EBITDA
for InflaRx NV.

Provide EV/EBIT
for InflaRx NV.

Provide EV/OCF
for InflaRx NV.

Provide EV/FCFF
for InflaRx NV.

Provide EV/IC
for InflaRx NV.

Show me price targets
for InflaRx NV made by professional analysts.

What are the Revenue projections
for InflaRx NV?

How accurate were the past Revenue estimates
for InflaRx NV?

What are the Net Income projections
for InflaRx NV?

How accurate were the past Net Income estimates
for InflaRx NV?

What are the EPS projections
for InflaRx NV?

How accurate were the past EPS estimates
for InflaRx NV?

What are the EBIT projections
for InflaRx NV?

How accurate were the past EBIT estimates
for InflaRx NV?

Compare the revenue forecasts
for InflaRx NV with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of InflaRx NV and its key competitors using the latest financial data.

Compare historical revenue growth rates
of InflaRx NV against its competitors.

Analyze the profit margins
(gross, operating, and net) of InflaRx NV compared to its peers.

Compare the P/E ratios
of InflaRx NV against its peers.

Discuss the investment returns and shareholder value creation
comparing InflaRx NV with its peers.

Analyze the financial leverage
of InflaRx NV compared to its main competitors.

Show all profitability ratios
for InflaRx NV.

Provide ROE
for InflaRx NV.

Provide ROA
for InflaRx NV.

Provide ROIC
for InflaRx NV.

Provide ROCE
for InflaRx NV.

Provide Gross Margin
for InflaRx NV.

Provide Operating Margin
for InflaRx NV.

Provide Net Margin
for InflaRx NV.

Provide FCF Margin
for InflaRx NV.

Show all solvency ratios
for InflaRx NV.

Provide D/E Ratio
for InflaRx NV.

Provide D/A Ratio
for InflaRx NV.

Provide Interest Coverage Ratio
for InflaRx NV.

Provide Altman Z-Score Ratio
for InflaRx NV.

Provide Quick Ratio
for InflaRx NV.

Provide Current Ratio
for InflaRx NV.

Provide Cash Ratio
for InflaRx NV.

What is the historical Revenue growth
over the last 5 years for InflaRx NV?

What is the historical Net Income growth
over the last 5 years for InflaRx NV?

What is the current Free Cash Flow
of InflaRx NV?

Discuss the annual earnings per share (EPS)
trend over the past five years for InflaRx NV.

Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
InflaRx NV

Current Assets 73.6m
Cash & Short-Term Investments 57.9m
Receivables 2.3m
Other Current Assets 13.4m
Non-Current Assets 6.1m
Long-Term Investments 4.7m
PP&E 1.1m
Intangibles 43.8k
Other Non-Current Assets 217.5k
Current Liabilities 13.9m
Accounts Payable 11.7m
Other Current Liabilities 2.1m
Non-Current Liabilities 535.8k
Long-Term Debt 535.8k
Other Non-Current Liabilities -10
Efficiency

Earnings Waterfall
InflaRx NV

Revenue
168.5k EUR
Cost of Revenue
-773.3k EUR
Gross Profit
-604.8k EUR
Operating Expenses
-55.9m EUR
Operating Income
-56.6m EUR
Other Expenses
-331.2k EUR
Net Income
-56.9m EUR

Free Cash Flow Analysis
InflaRx NV

Last Value
3-Years Average
FCF Margin
Conversion Rate
Fundamental Scores

IFRX Profitability Score
Profitability Due Diligence

InflaRx NV's profitability score is 17/100. The higher the profitability score, the more profitable the company is.

Exceptional Revenue Growth Forecast
Exceptional 1-Year Revenue Growth
Declining ROE
Declining ROIC
17/100
Profitability
Score

InflaRx NV's profitability score is 17/100. The higher the profitability score, the more profitable the company is.

IFRX Solvency Score
Solvency Due Diligence

InflaRx NV's solvency score is 55/100. The higher the solvency score, the more solvent the company is.

Short-Term Solvency
Long-Term Solvency
Negative Net Debt
Low D/E
55/100
Solvency
Score

InflaRx NV's solvency score is 55/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

IFRX Price Targets Summary
InflaRx NV

Wall Street analysts forecast IFRX stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for IFRX is 8.77 USD with a low forecast of 5.05 USD and a high forecast of 13.65 USD.

Lowest
Price Target
5.05 USD
125% Upside
Average
Price Target
8.77 USD
292% Upside
Highest
Price Target
13.65 USD
509% Upside
View Analyst Estimates
View Analyst Estimates
Want to learn more about Wall St estimates for IFRX?

Click here to dive deeper.

Dividends

InflaRx NV
does not pay dividends
Shareholder Yield

Current shareholder yield for IFRX is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

See Also

Discover More
What is the Intrinsic Value of one IFRX stock?

The intrinsic value of one IFRX stock under the Base Case scenario is 1.95 USD.

Is IFRX stock undervalued or overvalued?

Compared to the current market price of 2.24 USD, InflaRx NV is Overvalued by 13%.

Back to Top